128 related articles for article (PubMed ID: 37531252)
1. Modulation of host glutamine anabolism enhances the sensitivity of small cell lung cancer to chemotherapy.
Kodama M; Toyokawa G; Sugahara O; Sugiyama S; Haratake N; Yamada Y; Wada R; Takamori S; Shimokawa M; Takenaka T; Tagawa T; Kittaka H; Tsuruda T; Tanaka K; Komatsu Y; Nakata K; Imado Y; Yamazaki K; Okamoto I; Oda Y; Takahashi M; Izumi Y; Bamba T; Shimizu H; Yoshizumi T; Nakayama KI
Cell Rep; 2023 Aug; 42(8):112899. PubMed ID: 37531252
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Hallmarks for Purine Nucleotide Biosynthesis in Small Cell Lung Carcinoma.
Tabata S; Umemura S; Narita M; Udagawa H; Ishikawa T; Tsuboi M; Goto K; Ishii G; Tsuchihara K; Ochiai A; Kobayashi SS; Soga T; Makinoshima H
Mol Cancer Res; 2024 Jan; 22(1):82-93. PubMed ID: 37773022
[TBL] [Abstract][Full Text] [Related]
3. Purine de novo synthesis as the basis of synergism of methotrexate and 6-mercaptopurine in human malignant lymphoblasts of different lineages.
Bökkerink JP; Bakker MA; Hulscher TW; De Abreu RA; Schretlen ED
Biochem Pharmacol; 1988 Jun; 37(12):2321-7. PubMed ID: 2455519
[TBL] [Abstract][Full Text] [Related]
4. Regulation of purine synthesis de novo in human fibroblasts by purine nucleotides and phosphoribosylpyrophosphate.
Becker MA; Kim M
J Biol Chem; 1987 Oct; 262(30):14531-7. PubMed ID: 2444588
[TBL] [Abstract][Full Text] [Related]
5. [Clinical pharmacology of anticancer agents [Part 5] Antimetabolites (2)].
Nakamura T; Ueda T; Uchida M
Gan To Kagaku Ryoho; 1992 Mar; 19(3):409-20. PubMed ID: 1543370
[TBL] [Abstract][Full Text] [Related]
6. On the biochemical modulation of 6-mercaptopurine by methotrexate in murine WEHI-3b leukemia cells in vitro.
Liliemark J; Pettersson B; Peterson C
Leuk Res; 1992; 16(3):275-80. PubMed ID: 1373210
[TBL] [Abstract][Full Text] [Related]
7. Sequence-, time- and dose-dependent synergism of methotrexate and 6-mercaptopurine in malignant human T-lymphoblasts.
Bökkerink JP; Bakker MA; Hulscher TW; De Abreu RR; Schretlen ED; van Laarhoven JP; De Bruyn CH
Biochem Pharmacol; 1986 Oct; 35(20):3549-55. PubMed ID: 2429667
[TBL] [Abstract][Full Text] [Related]
8. Amidophosphoribosyltransferase limits the rate of cell growth-linked de novo purine biosynthesis in the presence of constant capacity of salvage purine biosynthesis.
Yamaoka T; Kondo M; Honda S; Iwahana H; Moritani M; Ii S; Yoshimoto K; Itakura M
J Biol Chem; 1997 Jul; 272(28):17719-25. PubMed ID: 9211923
[TBL] [Abstract][Full Text] [Related]
9. Salvage capacity of hepatoma 3924A and action of dipyridamole.
Weber G; Lui MS; Natsumeda Y; Faderan MA
Adv Enzyme Regul; 1983; 21():53-69. PubMed ID: 6443595
[TBL] [Abstract][Full Text] [Related]
10. Targeted and non-targeted actions of anti-cancer drugs.
Weber G; Prajda N
Adv Enzyme Regul; 1994; 34():71-89. PubMed ID: 7942286
[TBL] [Abstract][Full Text] [Related]
11. Feedback inhibition of amidophosphoribosyltransferase regulates the rate of cell growth via purine nucleotide, DNA, and protein syntheses.
Yamaoka T; Yano M; Kondo M; Sasaki H; Hino S; Katashima R; Moritani M; Itakura M
J Biol Chem; 2001 Jun; 276(24):21285-91. PubMed ID: 11290738
[TBL] [Abstract][Full Text] [Related]
12. Effects of methotrexate on nucleotide pools in normal human T cells and the CEM T cell line.
Budzik GP; Colletti LM; Faltynek CR
Life Sci; 2000; 66(23):2297-307. PubMed ID: 10855951
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Determinants of Sensitivity to Phosphatidylinositol 3-Kinase Pathway Inhibitor in Small-Cell Lung Carcinoma.
Makinoshima H; Umemura S; Suzuki A; Nakanishi H; Maruyama A; Udagawa H; Mimaki S; Matsumoto S; Niho S; Ishii G; Tsuboi M; Ochiai A; Esumi H; Sasaki T; Goto K; Tsuchihara K
Cancer Res; 2018 May; 78(9):2179-2190. PubMed ID: 29490947
[TBL] [Abstract][Full Text] [Related]
14. Enzymic capacities of purine de Novo and salvage pathways for nucleotide synthesis in normal and neoplastic tissues.
Natsumeda Y; Prajda N; Donohue JP; Glover JL; Weber G
Cancer Res; 1984 Jun; 44(6):2475-9. PubMed ID: 6327016
[TBL] [Abstract][Full Text] [Related]
15. Dose-related effects of methotrexate on purine and pyrimidine nucleotides and on cell-kinetic parameters in MOLT-4 malignant human T-lymphoblasts.
Bökkerink JP; De Abreu RA; Bakker MA; Hulscher TW; Van Baal JM; De Vaan GA
Biochem Pharmacol; 1986 Oct; 35(20):3557-64. PubMed ID: 2429668
[TBL] [Abstract][Full Text] [Related]
16. De novo synthesis of purine nucleotides in human peripheral blood leukocytes. Excessive activity of the pathway in hypoxanthine-guanine phosphoribosyltransferase deficiency.
Brosh S; Boer P; Kupfer B; de Vries A; Sperling O
J Clin Invest; 1976 Aug; 58(2):289-97. PubMed ID: 956368
[TBL] [Abstract][Full Text] [Related]
17. Regulation of de novo purine biosynthesis in normal and 8-azaguanine-resistant Chinese hamster cells.
Taylor MW; Tokito MK; Gupta KC; Pipkorn J
Biochim Biophys Acta; 1978 Jan; 517(1):1-13. PubMed ID: 203317
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of guanosine monophosphate synthetase (GMPS) blocks glutamine metabolism and prostate cancer growth.
Wang Q; Guan YF; Hancock SE; Wahi K; van Geldermalsen M; Zhang BK; Pang A; Nagarajah R; Mak B; Freidman N; Horvath LG; Turner N; Holst J
J Pathol; 2021 Jun; 254(2):135-146. PubMed ID: 33768538
[TBL] [Abstract][Full Text] [Related]
19. De novo purine synthesis inhibition and antileukemic effects of mercaptopurine alone or in combination with methotrexate in vivo.
Dervieux T; Brenner TL; Hon YY; Zhou Y; Hancock ML; Sandlund JT; Rivera GK; Ribeiro RC; Boyett JM; Pui CH; Relling MV; Evans WE
Blood; 2002 Aug; 100(4):1240-7. PubMed ID: 12149204
[TBL] [Abstract][Full Text] [Related]
20. The interaction of 6-mercaptopurine (6-MP) and methotrexate (MTX).
Giverhaug T; Loennechen T; Aarbakke J
Gen Pharmacol; 1999 Oct; 33(4):341-6. PubMed ID: 10523073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
